Terray Therapeutics Closes $120M Series B For AI Drug Pipeline
17 Oct 2024 //
BUSINESSWIRE
Ray Therapeutics Appoints Christopher Whitmore As CFO
16 Sep 2024 //
BUSINESSWIRE
Ray Therapeutics Receives $4M in Funding
13 Nov 2023 //
BUSINESSWIRE
Ray Therapeutics Announces Promotion of Jenny Holt to Chief Development Officer
21 Aug 2023 //
BUSINESSWIRE
Adverum Grants License to Ray Therapeutics for the AAV.7m8 Intravitreal Capsid
12 Jun 2023 //
GLOBENEWSWIRE
Ray Therapeutics Closes Oversubscribed $100M Series A Financing
16 May 2023 //
BUSINESSWIRE
Ray Therapeutics and Forge Biologics Expand Their Viral Vector cGMP Partnership
10 Oct 2022 //
BUSINESSWIRE
Spencer Health Solutions Partners with Ganse Apothecary
26 Apr 2022 //
BUSINESSWIRE
Ray Tx, Forge Biologics Enter Gene Therapy Mfg. Pact
01 Mar 2022 //
CONTRACTPHARMA
Ray Tx, Forge Biologics Announce Viral Vector Contract Development
01 Mar 2022 //
BUSINESSWIRE